Naloxone Continues Reversing Opioid Overdoses, Study Shows

Originally published on Forbes in June 2015.

As the medical community continues searching for ways to curb opioid-related deaths through treatment and management, the pharmaceutical industry proceeds with pushing for naloxone, a generic drug also known as Narcan — and the results are paying off.

A new Morbidity and Mortality Weekly Report (MMWR) published by the Centers for Disease Control and Prevention (CDC) revealed that naloxone kits were responsible for 26,463 overdose reversals during an 18-year period.

The Harm Reduction Coalition (HRC), an organization dedicated to advocating for broader access to naloxone, an opioid antagonist used to reverse the effects of narcotic drugs, surveyed 136 organizations that provided naloxone kits to 152,283 laypersons from 1996 through June 2014.

Keep reading …

Advertisements

Don’t Fret About Your Google Chromebook

I recently made the decision to purchase an ASUS C300MA Chromebook for work — even though I really wanted a MacBook Air. To be honest, I made the decision based purely on price. But then I realized there was something more to it than that.

I understood my needs. I purchased the Google Chromebook because it enables me to continue what I’ve been doing — make money. The majority of my income comes from writing, editing stories for several brands — so instead of going with what I wanted, I took a look at what I needed  — and it’s paying off.

Continue reading

Should Physicians Prescribing Opioids Be Confident In Managing Chronic Pain?

Originally published on Forbes.com in June 2015.

A physician’s confidence level when writing a prescription for a patient typically isn’t questioned, but maybe it should be — especially when it comes to practitioners prescribing opioids for chronic pain.

A new report revealed that only 25% of physicians who are certified to prescribe opioids believe they are “very confident” in their skills to manage patients using these drugs. The Boston University School of Medicine (BUSM) and myCME, Haymarket Medical Education’s global medical education website, released the results of the survey.

Low confidence levels in physicians could be the result of little to no training focusing on safe opioid prescribing and management. Dr. Daniel Alford, director of BUSM’s Safe and Competent Opioid Prescribing Education (SCOPE of Pain) program, said that this topic isn’t covered much in medical school or residency training.

Visit Forbes.com to read the rest of the article.